Stem Cells and Multiple Sclerosis at #ACTRIMS2016

0
(0)

The ACTRIMS Forum is a great initiative that gives researchers and clinicians in the MS field the opportunity to learn about new discoveries in the pathogenesis and management of the disease from world-renowned experts.

In this MSWorld video, Dr. Daniel Kantor talks with Dr. Michael Racke, Professor of Neurology and Neurosciences at Ohio State University about stem cells and multiple sclerosis, and how this treatment option can be used to help patients with MS.

Read more on how progression of some forms of MS can be halted with stem cells treatment.

Multiple Sclerosis News Today is strictly a news and information website about the disease. It does not provide medical advice, diagnosis or treatment. This content is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or another qualified health provider with any questions you may have regarding a medical condition. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.

How useful was this post?

Click on a star to rate it!

Average rating 0 / 5. Vote count: 0

No votes so far! Be the first to rate this post.

As you found this post useful...

Follow us on social media!

We are sorry that this post was not useful for you!

Let us improve this post!

Tell us how we can improve this post?

One comment

  1. Susan Schroder says:

    What you are not hearing here is that these scam stem cell treatments don’t involve chemotherapy. Real HSCT is happening and available in Russia, Germany, Mexico, Israel, and a few more countries.
    Not all of us in the US can qualify for a clinical trial, and I for one am now in my late 50’s and considered too old.
    I encourage people interested in HSCT to do their research and become more informed.
    I did, and am looking forward to treatment in Clinica Ruiz, in Puebla Mexico.

Leave a Comment

Your email address will not be published. Required fields are marked *